FDA Inspection 890624 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 1000138168

The FDA completed an inspection of New York Blood Center Enterprises on Aug 8, 2014 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 8, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Hyde Park, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.